Results 71 to 80 of about 21,592 (229)

Romosozumab Followed by Antiresorptive Treatment Increases the Probability of Achieving Bone Mineral Density Treatment Goals

open access: yesJBMR Plus, 2021
Increases in bone mineral density (BMD) with osteoporosis treatment are associated with reduced fracture risk. Increasing BMD is therefore a goal of osteoporosis therapy.
Felicia Cosman   +11 more
doaj   +1 more source

Algorithm for Surgical Management in Patients in Treatment With Medication Associated With Osteonecrosis of the Jaws

open access: yesOral Surgery, EarlyView.
ABSTRACT Background Osteonecrosis of the jaws is associated with various drugs, including antiresorptives such as bisphosphonates and denosumab, as well as antiangiogenics. These drugs are used for the treatment of multiple diseases, notably osteoporosis, bone metastases, Paget's disease, osteogenesis imperfecta, malignant hypocalcaemia, among others ...
Rodríguez Naranjo Julia Alexandra   +3 more
wiley   +1 more source

Comparison of the Efficacy of Daily and Weekly Oral Alendronate Treatment in Patients with Secondary Osteoporosis

open access: yesJournal of Behçet Uz Children's Hospital, 2019
INTRODUCTION: The use of alendronate, one of the bisphosphonates that can be used orally in the treatment of osteoporosis, has become widespread in recent years.
Sezer Acar   +4 more
doaj   +1 more source

Cost-Effectiveness of Alendronate in the Treatment of Osteoporosis in Denmark - An Economic Evaluation Based on the Fracture Intervention Trial [PDF]

open access: yes
Background: The Fracture Intervention Trial (FIT) showed that the bisphosphonate alendronate reduces the risk of fractures in women with low bone mass in the United States. Objective: To estimate the cost-effectiveness (cost per life-year gained and cost
Jönsson, Linus   +2 more
core  

Seizures after alendronate

open access: yesJRSM, 2002
Alendronate and other bisphosphonates are effective in the prevention and treatment of osteoporosis by inhibiting bone resorption. In normal circumstances a small initial fall in serum calcium has no clinical consequences because it is corrected by an increase in parathyroid hormone (PTH) secretion1.
Richard J, Maclsaac   +2 more
openaire   +3 more sources

Can Knee Arthroscopy Be Considered Entirely Safe for Patients Over 50 Years Old With no Risk of Osteonecrosis? Case Series and Literature Review on Post‐Artrhoscopy Osteonecrosis of the Knee (PAONK)

open access: yesOrthopaedic Surgery, Volume 17, Issue 5, Page 1378-1388, May 2025.
Post‐arthroscopy osteonecrosis is a rare complication occurring in 0.82% of cases, primarily affecting patients over 50 with degenerative meniscal tears. Early detection through MRI and conservative treatment, including bisphosphonates and weight‐bearing avoidance, proved effective in most cases, while some required surgical intervention.
Panagiotis Ntagiopoulos   +9 more
wiley   +1 more source

Effect of alendronate on survival and bone properties in Nothobranchius furzeri: insights from a model of accelerated aging

open access: yesExperimental Gerontology
Alendronate effectively inhibits osteoclastic bone resorption and is considered as first line treatment of osteoporosis. Additionally, several studies suggest a beneficial effect on mortality that goes beyond life-extending effects attributed to the well-
Maria Butylina   +7 more
doaj   +1 more source

Intragastric Alendronate Therapy İn Two İnfants With Vitamin D İntoxication: A New Method

open access: yes, 2008
In recent years, alendronate, an oral biphosphonate, has been added to therapy of hypercalcemia secondary to vitamin D intoxication in children. Alendronate may cause mucosal ulcerations in the mouth and esophagus. We report our experience in two infants
Ibrahim Caner   +11 more
core   +1 more source

From pill to pain: Alendronate‐induced esophageal injury—A case report and review

open access: yesJGH Open
Background Alendronate is used to treat Paget's bone disease, glucocorticoid‐induced osteoporosis, and postmenopausal osteoporosis because it suppresses osteoclast activity to stop bone resorption.
Zhen Fan   +6 more
doaj   +1 more source

Efficacy of generic alendronate and ibandronate in post menopausal osteoporosis

open access: yesSri Lanka Journal of Diabetes Endocrinology and Metabolism, 2012
Objective: To determine whether generic non innovator once weekly oral alendronate is as effective as the innovator once oral Ibandronate.Method: This was an open label, prospective, randomized control trial conducted at the endocrine unit at the ...
NP Somasundaram   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy